Literature DB >> 24098002

The challenge of pregnancy for patients with SLE.

O Ateka-Barrutia1, M A Khamashta.   

Abstract

Pregnancy poses an important challenge for doctors looking after women with systemic lupus erythematosus. Knowledge about safety of medications, the effect of pregnancy on such disease, and vice versa, together with multidisciplinary team care, are basic cornerstones needed to provide the best obstetric and medical care to these women. Pre-conceptional counselling constitutes the ideal scenario where a patient's previous obstetric history, organ damage, disease activity, serological profile and additional medical history can be summarized. Important issues regarding medication adjustment, planned scans and visits, and main risks discussion should also be raised at this stage. Planned pregnancies lead to better outcomes for both mothers and babies. Close surveillance throughout pregnancy and the puerperium, and tailored management approach guarantee the highest rates of successful pregnancies in these women.

Entities:  

Keywords:  Pregnancy; management; medications; pre-pregnancy counselling; systemic lupus erythematosus

Mesh:

Year:  2013        PMID: 24098002     DOI: 10.1177/0961203313504637

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

1.  Predictors of maternal and fetal complications in SLE patients: a prospective study.

Authors:  Elisabetta Borella; Andrea Lojacono; Mariele Gatto; Laura Andreoli; Marco Taglietti; Luca Iaccarino; Edoardo Casiglia; Leonardo Punzi; Angela Tincani; Andrea Doria
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

3.  Oral corticosteroid use during pregnancy and risk of preterm birth.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Min Xi; Diana L Johnson; Ronghui Xu; Christina D Chambers
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

4.  Differences in the Association Between Oral Glucocorticoids and Risk of Preterm Birth by Data Source: Reconciling the Results.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Christina D Chambers
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-05-20       Impact factor: 5.178

5.  Brief Report: Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis.

Authors:  Elizabeth V Arkema; Johan Askling; Jane E Salmon; Julia F Simard
Journal:  Arthritis Rheumatol       Date:  2016-12-02       Impact factor: 10.995

6.  Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose.

Authors:  Kristin Palmsten; Matthieu Rolland; Mary F Hebert; Megan E B Clowse; Michael Schatz; Ronghui Xu; Christina D Chambers
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-28       Impact factor: 2.890

Review 7.  Renal involvement in antiphospholipid syndrome.

Authors:  Savino Sciascia; Maria José Cuadrado; Munther Khamashta; Dario Roccatello
Journal:  Nat Rev Nephrol       Date:  2014-03-18       Impact factor: 28.314

8.  "I know my body better than you:" patient focus groups to inform a decision aid on oral corticosteroid use during pregnancy.

Authors:  Kristin Palmsten; Dani Bredesen; Meghan M JaKa; Pritika C Kumar; Jeanette Y Ziegenfuss; Elyse O Kharbanda
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-12-22       Impact factor: 2.890

9.  Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program.

Authors:  Kristin Palmsten; Gretchen Bandoli; Jim Watkins; Gabriela Vazquez-Benitez; Todd P Gilmer; Christina D Chambers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-11

10.  Experiences of Iranian female patients with systemic lupus erythematosus: A qualitative study.

Authors:  Zahra Behboodi Moghadam; Seyedeh Tahereh Faezi; Armin Zareian; Elham Rezaei
Journal:  Arch Rheumatol       Date:  2020-12-10       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.